...
首页> 外文期刊>Virology >Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
【24h】

Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.

机译:多价DNA初免/蛋白质加强HIV-1疫苗引起的细胞免疫反应的临床前评估。

获取原文
获取原文并翻译 | 示例

摘要

While DNA vaccines have been shown to prime cellular immune responses, levels are often low in nonhuman primates or humans. Hence, efforts have been directed toward boosting responses by combining DNA with different vaccination modalities. To this end, a polyvalent DNA prime/protein boost vaccine, consisting of codon optimized HIV-1 env (A, B, C, E) and gag (C) and homologous gp120 proteins in QS-21, was evaluated in rhesus macaques and BALB/c mice. Humoral and cellular responses, detected following DNA immunization, were increased following protein boost in macaques and mice. In dissecting cellular immune responses in mice, protein-enhanced responses were found to be mediated by CD4+ and CD8+ T cells with a Th1 cytokine bias. Our study reveals that, in addition to augmenting humoral responses, protein boosting of DNA-primed animals augments cellular immune responses mediated by CD8+ CTL, CD4+ T-helper cells and Th1 cytokines; thus, offering much promise in controlling HIV-1 in vaccinees.
机译:尽管已经证明DNA疫苗可引发细胞免疫反应,但在非人类灵长类动物或人类中,其水平通常较低。因此,已经致力于通过结合具有不同疫苗接种方式的DNA来增强应答。为此,在恒河猴和猕猴中评估了一种多价DNA初免/蛋白质加强疫苗,该疫苗由经密码子优化的HIV-1 env(A,B,C,E)和gag(C)和同源gp120蛋白组成。 BALB / c小鼠。 DNA免疫后检测到的体液和细胞反应随着猕猴和小鼠中蛋白质的增强而增加。在解剖小鼠的细胞免疫反应中,发现蛋白增强反应是由具有Th1细胞因子偏倚的CD4 +和CD8 + T细胞介导的。我们的研究表明,除了增强体液反应外,DNA引发动物的蛋白质增强还增强了CD8 + CTL,CD4 + T辅助细胞和Th1细胞因子介导的细胞免疫反应。因此,为控制疫苗中的HIV-1提供了广阔的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号